Compare NCEL & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCEL | MMA |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Switzerland | Australia |
| Employees | 11 | 22 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 11.8M |
| IPO Year | N/A | 2023 |
| Metric | NCEL | MMA |
|---|---|---|
| Price | $2.52 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 17.4K | ★ 316.8K |
| Earning Date | 03-27-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.83 | $0.35 |
| 52 Week High | $4.70 | $2.00 |
| Indicator | NCEL | MMA |
|---|---|---|
| Relative Strength Index (RSI) | 57.44 | 50.74 |
| Support Level | $2.50 | $0.35 |
| Resistance Level | $3.16 | $0.50 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 99.99 | 81.76 |
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.
MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.